229 related articles for article (PubMed ID: 17261983)
1. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
2. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and immunohistochemical analysis of malignant features in mucinous cystic tumors of the pancreas.
Sawai H; Okada Y; Funahashi H; Matsuo Y; Hayakawa T; Tanaka M; Takeyama H; Manabe T
Hepatogastroenterology; 2006; 53(68):286-90. PubMed ID: 16608041
[TBL] [Abstract][Full Text] [Related]
4. P53 and MIB-1 expression in gastrointestinal stromal tumor (GIST) of the stomach.
Hata Y; Ishigami S; Natsugoe S; Nakajo A; Okumura H; Miyazono F; Matsumoto M; Hokita S; Aikou T
Hepatogastroenterology; 2006; 53(70):613-5. PubMed ID: 16995473
[TBL] [Abstract][Full Text] [Related]
5. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53.
Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC
Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of gastrointestinal stromal tumors in the stomach.
Okubo K; Yamao K; Nakamura T; Tajika M; Sawaki A; Hara K; Kawai H; Yamamura Y; Mochizuki Y; Koshikawa T; Inada K
J Gastroenterol; 2004 Aug; 39(8):747-53. PubMed ID: 15338368
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducible factor-1alpha is associated with risk of aggressive behavior and tumor angiogenesis in gastrointestinal stromal tumor.
Chen WT; Huang CJ; Wu MT; Yang SF; Su YC; Chai CY
Jpn J Clin Oncol; 2005 Apr; 35(4):207-13. PubMed ID: 15845570
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
10. Significance of p53 expression in gastrointestinal stromal tumors.
Yalcinkaya U; Yerci O; Koc EU
Hepatogastroenterology; 2007; 54(73):140-3. PubMed ID: 17419248
[TBL] [Abstract][Full Text] [Related]
11. The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.
Chou YP; Lin JW; Wang CC; Chiu YC; Huang CC; Chuah SK; Tai MH; Yi LN; Lee CM; Changchien CS; Hu TH
Oncol Rep; 2008 Jan; 19(1):49-56. PubMed ID: 18097575
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 63 cases with gastric gastrointestinal stromal tumors].
Rong L; Wan YL; Nian WD; Liu P; Liang JY
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):24-7. PubMed ID: 19145498
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic resection of clinically suspected gastric stromal tumors.
Berindoague R; Targarona EM; Feliu X; Artigas V; Balagué C; Aldeano A; Lahoud A; Navines J; Fernandez-Sallent E; Trias M
Surg Innov; 2006 Dec; 13(4):231-7. PubMed ID: 17227921
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes and immunohistochemical features for gastrointestinal stromal tumors (GISTS) of the stomach: with special reference to prognostic factors.
Park SS; Ryu JS; Oh SY; Kim WB; Lee JH; Chae YS; Kim SJ; Kim CS; Mok YJ
Hepatogastroenterology; 2007; 54(77):1454-7. PubMed ID: 17708275
[TBL] [Abstract][Full Text] [Related]
15. Survival and prognostic factors analysis in surgically resected gastrointestinal stromal tumor patients.
Song Z; Wang JL; Pan YL; Tao DY; Gan MF; Huang KE
Hepatogastroenterology; 2009; 56(89):149-53. PubMed ID: 19453047
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumors: a 19 year experience.
Rabin I; Chikman B; Lavy R; Sandbank J; Maklakovsky M; Gold-Deutch R; Halpren Z; Wassermann I; Halevy A
Isr Med Assoc J; 2009 Feb; 11(2):98-102. PubMed ID: 19432038
[TBL] [Abstract][Full Text] [Related]
17. The expression of p53 and bcl-2 in gastrointestinal stromal tumours is associated with anatomical site, and p53 expression is associated with grade and clinical outcome.
Feakins RM
Histopathology; 2005 Mar; 46(3):270-9. PubMed ID: 15720412
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity as prognostic factor in gastrointestinal stromal tumors of the stomach.
Kawai J; Kodera Y; Fujiwara M; Kasai Y; Nagasaka T; Koike M; Hibi K; Ito K; Akiyama S; Nakao A
Hepatogastroenterology; 2005; 52(63):959-64. PubMed ID: 15966241
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of KIT-negative gastrointestinal stromal tumours and diagnostic utility of protein kinase C theta immunostaining.
Lee HE; Kim MA; Lee HS; Lee BL; Kim WH
J Clin Pathol; 2008 Jun; 61(6):722-9. PubMed ID: 18381383
[TBL] [Abstract][Full Text] [Related]
20. Elevated p21 expression is associated with poor prognosis of rectal stromal tumors after resection.
Hu TH; Tai MH; Chuah SK; Chen HH; Lin JW; Huang HY; Chou YP; Yi LN; Kuo CM; Changchien CS
J Surg Oncol; 2008 Aug; 98(2):117-23. PubMed ID: 18521824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
